Free Trial Information
BioCentury | Jan 14, 2013
Company News

Alize Pharma, Bertin Technologies S.A.S., Ricerca, French National Institute of Health and Medical Research (Inserm), Lyon School of Veterinary Medicine cardiov

...partners. Alize Pharma S.A.S. , Lyon, France Bertin Technologies S.A.S. , Montigny le Bretonneux, France Ricerca...
Read More
BioCentury | Feb 11, 2008
Company News

Ricerca management update

Ricerca Biosciences LLC , Concord, Ohio Business: Supply/Service, Chemistry Transitioned: R. Ian Lennox to chairman and CEO from executive chairman WIR Staff...
Read More
BioCentury | Dec 10, 2004
Company News

Ricerca spins out cancer company

Ricerca Biosciences (Concord, Ohio) spun out Auburn Pharmaceuticals to develop a pair of cancer compounds in preclinical testing to increase tumor susceptibility to radiation. Auburn's lead product is chelerythrine , a radiation sensitizer that is slated...
Read More
BioCentury | Oct 27, 2003
Company News

Chiral Quest management update

...Hired: Ronald Brandt as VP of business development, formerly EVP of marketing and sales at Ricerca...
Read More
BioCentury | Apr 21, 2003
Company News

Ricerca management update

Ricerca Biosciences LLC , Concord, Ohio Business: Supply/Service Hired: Thomas Bradshaw as interim CEO, while remaining president of Venture Biologics L.L.P.; he replaces Prabhavathi Fernandes, who departed WIR Staff...
Read More
BioCentury | Apr 15, 2003
Company News

Ricerca names Bradshaw as interim CEO

...Discovery services company Ricerca (Concord, Ohio) hired Thomas Bradshaw as interim CEO. Bradshaw is president of...
Read More
BioCentury | Mar 17, 2003
Company News

Ricerca, PrimaScreen Inc. deal

...VHD) toxicological assay platform. The combined product will be offered to the drug development market. Ricerca...
...funding, infrastructure and facilities in exchange for co-marketing rights and an equity stake in PrimaScreen. Ricerca...
Read More
BioCentury | Dec 9, 2002
Company News

Ricerca, Eli Lilly deal

...Ricerca received an exclusive license to certain LLY antibacterial targets and IP. Ricerca may develop and...
...upfront payment and an equity stake in Ricerca, and is eligible for milestones and royalties. Ricerca...
Read More
BioCentury | Dec 4, 2002
Company News

Ricerca, Lilly antibacterial deal

...Ricerca (Concord, Ohio) received an exclusive license to certain LLY antibacterial targets and IP. Ricerca may...
...molecules against the targets. LLY will receive an upfront payment and an equity stake in Ricerca...
Read More
BioCentury | Nov 25, 2002
Company News

Ricerca management update

Ricerca Biosciences LLC , Concord, Ohio Business: Supply/Service Hired: Ronald Brandt as EVP of marketing and sales, formerly SVP of American sales at International Specialty Products WIR Staff...
Read More
Items per page:
1 - 10 of 29
BioCentury | Jan 14, 2013
Company News

Alize Pharma, Bertin Technologies S.A.S., Ricerca, French National Institute of Health and Medical Research (Inserm), Lyon School of Veterinary Medicine cardiov

...partners. Alize Pharma S.A.S. , Lyon, France Bertin Technologies S.A.S. , Montigny le Bretonneux, France Ricerca...
Read More
BioCentury | Feb 11, 2008
Company News

Ricerca management update

Ricerca Biosciences LLC , Concord, Ohio Business: Supply/Service, Chemistry Transitioned: R. Ian Lennox to chairman and CEO from executive chairman WIR Staff...
Read More
BioCentury | Dec 10, 2004
Company News

Ricerca spins out cancer company

Ricerca Biosciences (Concord, Ohio) spun out Auburn Pharmaceuticals to develop a pair of cancer compounds in preclinical testing to increase tumor susceptibility to radiation. Auburn's lead product is chelerythrine , a radiation sensitizer that is slated...
Read More
BioCentury | Oct 27, 2003
Company News

Chiral Quest management update

...Hired: Ronald Brandt as VP of business development, formerly EVP of marketing and sales at Ricerca...
Read More
BioCentury | Apr 21, 2003
Company News

Ricerca management update

Ricerca Biosciences LLC , Concord, Ohio Business: Supply/Service Hired: Thomas Bradshaw as interim CEO, while remaining president of Venture Biologics L.L.P.; he replaces Prabhavathi Fernandes, who departed WIR Staff...
Read More
BioCentury | Apr 15, 2003
Company News

Ricerca names Bradshaw as interim CEO

...Discovery services company Ricerca (Concord, Ohio) hired Thomas Bradshaw as interim CEO. Bradshaw is president of...
Read More
BioCentury | Mar 17, 2003
Company News

Ricerca, PrimaScreen Inc. deal

...VHD) toxicological assay platform. The combined product will be offered to the drug development market. Ricerca...
...funding, infrastructure and facilities in exchange for co-marketing rights and an equity stake in PrimaScreen. Ricerca...
Read More
BioCentury | Dec 9, 2002
Company News

Ricerca, Eli Lilly deal

...Ricerca received an exclusive license to certain LLY antibacterial targets and IP. Ricerca may develop and...
...upfront payment and an equity stake in Ricerca, and is eligible for milestones and royalties. Ricerca...
Read More
BioCentury | Dec 4, 2002
Company News

Ricerca, Lilly antibacterial deal

...Ricerca (Concord, Ohio) received an exclusive license to certain LLY antibacterial targets and IP. Ricerca may...
...molecules against the targets. LLY will receive an upfront payment and an equity stake in Ricerca...
Read More
BioCentury | Nov 25, 2002
Company News

Ricerca management update

Ricerca Biosciences LLC , Concord, Ohio Business: Supply/Service Hired: Ronald Brandt as EVP of marketing and sales, formerly SVP of American sales at International Specialty Products WIR Staff...
Read More
Items per page:
1 - 10 of 29